Literature DB >> 16954449

Management of thyroid disorders.

L D K E Premawardhana1, J H Lazarus.   

Abstract

Autoimmune thyroid disease is the predominant form of thyroid dysfunction in the developed world. Although its precise cause is currently unclear, principles of management have been established. There is a vigorous debate about the management of the increasingly commonly recognised subclinical forms of thyroid dysfunction despite recent recommendations. Nodular thyroid disease and thyroid carcinoma have received wide attention. The effects of drugs and pregnancy on thyroid function have also been investigated widely. This short review attempts to give an overview and clarify the current management of common thyroid disorders.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16954449      PMCID: PMC2585732          DOI: 10.1136/pgmj.2006.047290

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  38 in total

1.  Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease.

Authors:  Zubair Baloch; Pierre Carayon; Bernard Conte-Devolx; Laurence M Demers; Ulla Feldt-Rasmussen; Jean-François Henry; Virginia A LiVosli; Patricia Niccoli-Sire; Rhys John; Jean Ruf; Peter P A Smyth; Carole A Spencer; Jan R Stockigt
Journal:  Thyroid       Date:  2003-01       Impact factor: 6.568

Review 2.  Clinical review 169: Interferon-alpha-related thyroid disease: pathophysiological, epidemiological, and clinical aspects.

Authors:  C Carella; G Mazziotti; G Amato; L E Braverman; E Roti
Journal:  J Clin Endocrinol Metab       Date:  2004-08       Impact factor: 5.958

Review 3.  Recent developments in thyroid eye disease.

Authors:  Tom Cawood; Paul Moriarty; Donal O'Shea
Journal:  BMJ       Date:  2004-08-14

Review 4.  Clinical practice. The thyroid nodule.

Authors:  Laszlo Hegedüs
Journal:  N Engl J Med       Date:  2004-10-21       Impact factor: 91.245

Review 5.  Management of simple nodular goiter: current status and future perspectives.

Authors:  Laszlo Hegedüs; Steen J Bonnema; Finn N Bennedbaek
Journal:  Endocr Rev       Date:  2003-02       Impact factor: 19.871

6.  Combined thyroxine/liothyronine treatment does not improve well-being, quality of life, or cognitive function compared to thyroxine alone: a randomized controlled trial in patients with primary hypothyroidism.

Authors:  John P Walsh; Lauren Shiels; Ee Mun Lim; Chotoo I Bhagat; Lynley C Ward; Bronwyn G A Stuckey; Satvinder S Dhaliwal; Gerard T Chew; Minoti C Bhagat; Andrea J Cussons
Journal:  J Clin Endocrinol Metab       Date:  2003-10       Impact factor: 5.958

7.  The thyroid epidemiology, audit, and research study: thyroid dysfunction in the general population.

Authors:  R W V Flynn; T M MacDonald; A D Morris; R T Jung; G P Leese
Journal:  J Clin Endocrinol Metab       Date:  2004-08       Impact factor: 5.958

8.  Levels of autoantibodies against human TSH receptor predict relapse of hyperthyroidism in Graves' disease.

Authors:  M Schott; N G Morgenthaler; R Fritzen; J Feldkamp; H S Willenberg; W A Scherbaum; J Seissler
Journal:  Horm Metab Res       Date:  2004-02       Impact factor: 2.936

9.  Subclinical thyroid disease: clinical applications.

Authors:  Nananda F Col; Martin I Surks; Gilbert H Daniels
Journal:  JAMA       Date:  2004-01-14       Impact factor: 56.272

10.  Predictors of outcome and comparison of different drug regimens for the prevention of relapse in patients with Graves' disease.

Authors:  Bjorn G Nedrebo; Pal I Holm; Sverre Uhlving; Jan Inge Sorheim; Svein Skeie; Geir Egil Eide; Eystein S Husebye; Ernst A Lien; Sylvi Aanderud
Journal:  Eur J Endocrinol       Date:  2002-11       Impact factor: 6.664

View more
  2 in total

1.  Paracrine interactions of thyroid hormones and thyroid stimulation hormone in the female reproductive tract have an impact on female fertility.

Authors:  Anneli Stavreus Evers
Journal:  Front Endocrinol (Lausanne)       Date:  2012-03-30       Impact factor: 5.555

2.  Thyrotoxicosis and dilated cardiomyopathy in developing countries.

Authors:  Bisrat Tesfay Abera; Merhawit Atsbha Abera; Gebretsadik Berhe; Girmatsion Fisseha Abreha; Hirut Teame Gebru; Hiluf Ebuy Abraha; Mohamedawel Mohamedniguss Ebrahim
Journal:  BMC Endocr Disord       Date:  2021-06-28       Impact factor: 2.763

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.